About this trial
Idiopathic intracranial hypertension (IIH) is a condition of unknown etiology, primarily affecting overweight females of childbearing age. Typically, patients experience headache and visual symptoms due to increased intracranial pressure (ICP) and papilledema. The diagnosis is difficult, and outcomes vary from no sequelae to blindness or chronic headaches. No clear prognostic indicators exist. Treatment consists of medication, weight loss, and possibly surgical intervention.There is an unmet need of defining biomarkers with prognostic or diagnostic value and defining predictors of a poor outcome.
This project is a prospective, population-based cohort study including clinical data and a biobank (blood samples and cerebrospinal fluid).
The investigator's primary aim is to identify biomarkers of diagnostic or prognostic value and to create a clinical IIH database. The clinical database will answer questions about patient characteristics at baseline and during follow-up, identify predictors of outcome, and help create a standardized programme for follow-up and
Eligibility criteria
Qualifiers
Able to and willing to provide informed consent
More than 18 years of age
Suspicion of IIH (based on clinical evaluation by neurologist or opthalmologist)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Standard treatment
Treatment groups
Sponsors and collaborators
Danish Headache Center
Lead sponsor
Odense University Hospital
Collaborator